Clinical Studies

We know that a robust clinical and regulatory strategy delivers long-term value and confidence to your idea or concept. consult2deliver limited have extensive knowledge and experience of phase I clinical studies (Pharmacokinetic/Pharmacodynamic). We help companies develop clinical strategies, outline clinical programmes and given input to protocol development (Phase I-IV).

We can collaborate to create

  • Investigator Brochures (IB)
  • Investigational Medicinal Product Dossiers (IMPD)
  • Bibliographic reviews to validate idea/concept
  • Clinical strategy in line with regulation
  • Clinical strategy with/without scientific advice
  • Formal project planning
  • Analysis of data from clinical studies (I-III) to confirm alignment with clinical strategy
  • Study design and protocol preparation
  • Review clinical study reports (CSRs) to be fit for purpose

We work with a variety of clinical professionals who can help advise, shape and develop a study outline for your product development.